About this trial
This is an observational multicenter retrospective and prospective study on natural history of SMA also considering the 'new natural history' secondary to the availability of commercially available therapies.
All the patients enrolled to date in the Italian registry, if not part of clinical trials, will be included in the present study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
All patients affected by Spinal Muscular Atrophy 5q, irrespective of genotype, phenotype, age, treatment status or gender
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
motor function using the HFMSE (min score 0, max 74 indicating best performance)
motor scale
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead sponsor
University of Milan
Collaborator
Bambino Gesù Hospital and Research Institute
Collaborator
University of Messina
Collaborator
Gaslini Children's Hospital
Collaborator